CPIX

Cumberland Pharmaceuticals

-$2.6M

Net Activity

Institutions Holding

30

Popularity Rank

#7279

Avg Weight

0.01%

Total Value

$9.5M

Ownership Trend

30 institutions currently hold CPIX, with 14 net buyers and 14 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

14

Net Buying Institutions

14

Key Holders

View all 30 holding institutions

Quarterly Activity

Recent Activity

+$2.3M

Total Buy Value

$7.4M

Total Sell Value

New buy7
Trim9
Add7
Sold out5

14

Net Buyers

14

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

2

Filings (14d)

Data as of 2026-07-13
2026-07-13

Cumberland Pharmaceuticals declared a special cash dividend of $1.50 per share and a new $5 million stock buyback program, funded by higher-than-expected cash from its recent strategic transaction with Apotex. The company received $100 million upfront from the deal. Several board members also plan to increase their personal holdings in the company.

View Full Filing (SEC EDGAR)
2026-07-01

Cumberland Pharmaceuticals has amended its asset transfer agreement with Nuvo on July 1, 2026, to exclude certain contracts from the assets being sold. The filing does not provide details on which contracts are excluded.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding CUMBERLAND PHARMACEUTICALS (CPIX)?
Major stakeholders currently include Ikarian Capital, LLC ($1.8M), Renaissance Technologies LLC ($1.5M), Vanguard Capital Management LLC ($1.2M). Based on the latest 13F filings, there are a total of 30 tracked investment funds and institutions maintaining positions in CPIX.
What is the overall institutional sentiment toward CPIX recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $2.6M, driven by 14 managers accumulating shares while 14 reduced their exposure.
Which institutions have been selling or reducing their CPIX positions?
In the latest period, 9 funds trimmed their holdings, and 5 managers completely exited their positions. The aggregate reported sell value was $7.4M.
Are there any notable investors adding CPIX to their portfolios?
Yes, buying activity remains notable. 7 institutions opened new positions in {ticker}, and 7 existing holders added to their shares. The total reported buy value for the quarter amounted to $2.3M.

Related Stocks